Strategic Tech Initiatives in Lab Operations: Recipe(s) for Success - Insights
Skip to Content MayoACCESS MayoLINK...
Notice: New outgoing Mayo Lab Inquiry caller ID - Insights
Mayo Clinic Laboratories’ call center has a new outgoing caller ID number for any follow up client communications.
New Tests Launched in February - Insights
In February 2019, Mayo Clinic Laboratories announced one new test along with numerous reference value changes, obsolete tests, and algorithm changes.
Mayo Clinic develops and validates new antibody test to diagnose multiple sclerosis - Insights
Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research...
Five Steps to Improve Transfusion Medicine - Insights
Blood transfusion is the most common procedure performed in hospitals in the U.S. Yet published evidence shows significant gaps in clinicians' knowledge of this critical aspect of patient care, including possible adverse reactions that can...
Each day, some 40 to 45 thousand specimens are shipped to Mayo Clinic Laboratories in Rochester, Minnesota, from hospitals and other health care organizations around the world. And for every sample, there’s a patient to whom it belongs,...
Hereditary testing by specialty - Insights
Mayo Clinic Laboratories is a one-stop laboratory for hereditary testing, featuring a robust menu of molecular, cytogenic, biochemical, and functional assays that support diagnosis and care.
A "sandbox" for innovation: The Advanced Diagnostics Laboratory - Insights
Mayo Clinic’s Advanced Diagnostics Laboratory (ADL) is a visionary space designed to foster innovation. The ADL has a direct impact on patient lives, bringing promising tests and services to patients at Mayo and around the world.
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia (CLL) - Insights
In this month’s “Hot Topic,” Curtis Hanson, M.D., will discuss the use of laboratory-based prognostic markers in patients with chronic lymphocytic leukemia (CLL). He will also highlight the importance of molecular analyses for IGHV and TP53...
July 2019 — Cardiovascular - Insights
A 50-year-old man who was known to have systemic hypertension developed sudden onset of severe back pain with associated diaphoresis. He lost